title: Involvement of cholinergic mechanisms in the behavioral effects of dietary fat consumption.
abstract: Clinical reports suggest a positive association between fat consumption and the incidence of hyperactivity, impulsivity and cognitive abnormalities. To investigate possible mechanisms underlying these disturbances under short-term conditions, we examined in Sprague-Dawley rats the influence of 7-day consumption of a high-fat diet (HFD) compared to chow on anxiety, novelty-seeking and exploratory behaviors and also on acetylcholine (ACh) neurotransmission that may mediate these behaviors. The HFD consumption, which elevated circulating fatty acids but produced no change in caloric intake or body weight, stimulated novelty-seeking and exploration in an open field, while reducing anxiety in an elevated plus maze. Using the Ellman assay to measure ACh esterase (AChE) activity that breaks down ACh, the second experiment showed HFD consumption to significantly reduce AChE activity in the frontal cortex, hypothalamus and midbrain. With measurements of [¹²⁵I]-epibatidine or [¹²⁵I]-bungarotoxin binding to nicotinic ACh receptors (nAChRs) containing β2 or α7 subunits, respectively, the results also showed HFD consumption to increase both β2-nAChR binding in the medial prefrontal cortex and substantia nigra and α7-nAChR binding in the lateral and ventromedial hypothalamus. When treated with an acute dose of the nicotinic antagonist, mecamylamine (0.5 mg/kg, sc), the HFD animals responded with significantly reduced exploratory and novelty-seeking behaviors, whereas the chow-consuming rats exhibited no response. These findings suggest that the exploratory and novelty-seeking behaviors induced by dietary fat may be mediated by enhanced nicotinic cholinergic activity, which is accompanied by increased density of β2-nAChRs in cortical and midbrain regions associated with impulsivity and locomotor activity and of α7-nAChRs in hypothalamic regions associated with arousal and energy balance.
authors: The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.
authors: Irene
authors: I
authors: Morganstern
authors: Zhiy
authors: Z
authors: Ye
authors: Sherry
authors: S
authors: Liang
authors: Shawn
authors: S
authors: Fagan
authors: Sarah F
authors: SF
authors: Leibowitz
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D001007:Anxiety / Q000139:chemically induced; D001345:Autoradiography; D001522:Behavior, Animal / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D001931:Brain Mapping; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000493:pharmacokinetics; D002038:Bungarotoxins / Q000493:pharmacokinetics; D004041:Dietary Fats / Q000494:pharmacology*; D002149:Energy Intake / Q000187:drug effects; D005106:Exploratory Behavior / Q000187:drug effects; D005227:Fatty Acids / Q000378:metabolism; D007456:Iodine Isotopes / Q000493:pharmacokinetics; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D018722:Nicotinic Agonists / Q000493:pharmacokinetics; D011485:Protein Binding / Q000187:drug effects; D011725:Pyridines / Q000493:pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D011978:Receptors, Nicotinic / Q000378:metabolism
chemical_list: D000110:Acetylcholinesterase; D019086:Bridged Bicyclo Compounds, Heterocyclic; D002038:Bungarotoxins; D004041:Dietary Fats; D005227:Fatty Acids; D007456:Iodine Isotopes; D018722:Nicotinic Agonists; D011725:Pyridines; D011978:Receptors, Nicotinic; C082748:epibatidine